Old Mission Capital LLC Cellectis S.A. Transaction History

Old Mission Capital LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$1.83 - $3.84 $19,355 - $40,615	10,577 Added 90.0%	22,329 $43,000
Q4 2022 Feb 14, 2023	BUY	$1.85 - $2.6 $21,741 - $30,555	11,752 New	11,752 $24,000
Q2 2022 Aug 05, 2022	SELL	$2.39 - $4.93 $40,792 - $84,145	-17,068 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$3.45 - $8.77 $58,884 - $149,686	17,068 New	17,068 $77,000
Q1 2021 May 14, 2021	SELL	$18.19 - $33.25 $249,039 - $455,225	-13,691 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$15.7 - $20.84 $214,948 - $285,320	13,691 New	13,691 $253,000
Q4 2019 Feb 14, 2020	SELL	$9.73 - $19.31 $212,211 - $421,151	-21,810 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$10.15 - $16.89 $221,371 - $368,370	21,810 New	21,810 $227,000
Q1 2019 May 14, 2019	SELL	$15.53 - $19.75 $471,413 - $599,511	-30,355 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$15.58 - $28.41 $472,930 - $862,385	30,355 New	30,355 $505,000
Q3 2018 Nov 14, 2018	SELL	$25.99 - $30.6 $721,690 - $849,700	-27,768 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$27.78 - $38.53 $560,655 - $777,612	20,182 Added 266.04%	27,768 $786,000
Q1 2018 May 15, 2018	BUY	$27.78 - $35.19 $210,739 - $266,951	7,586 New	7,586 $239,000

11.2M

2.8K

17.9K

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $90.1M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

Get notified when there are updates to the investment portfolio of Old Mission Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Old Mission Capital LLC with notifications on news.